{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:13:14Z","timestamp":1790741594902,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/carcin\/bgx061","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T11:12:02Z","timestamp":1498129922000},"page":"812-820","source":"Crossref","is-referenced-by-count":22,"title":["Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma"],"prefix":"10.1093","volume":"38","author":[{"given":"Siria A","family":"Lemma","sequence":"first","affiliation":[{"name":"Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"},{"name":"Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milla","family":"Kuusisto","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"},{"name":"Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi-Maria","family":"Haapasaari","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"},{"name":"Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"},{"name":"Department of Pathology, Institute of Diagnostics, Medical Research Center Oulu, Oulu University Hospital, Kajaanintie 50, 90220 Oulu, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raija","family":"Sormunen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Diagnostics, Medical Research Center Oulu, Oulu University Hospital, Kajaanintie 50, 90220 Oulu, Finland,"},{"name":"Biocenter Oulu, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Lehtinen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Klaavuniemi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland,"},{"name":"Department of Oncology and Radiotherapy, Central Finland Central Hospital, Keskussairaalantie 19, 40620 Jyv\u00e4skyl\u00e4, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Eray","sequence":"additional","affiliation":[{"name":"Department of Pathology, FIMLAB, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa","family":"Jantunen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kuopio University Hospital, Puijonlaaksontie 2, 70210 Kuopio, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylermi","family":"Soini","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology and Forensic Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Puijonlaaksontie 2, 70210 Kuopio, Finland,"},{"name":"Kuopio University Hospital, Puijonlaaksontie 2, 70210 Kuopio, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaija","family":"Vasala","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, Central Finland Central Hospital, Keskussairaalantie 19, 40620 Jyv\u00e4skyl\u00e4, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Department of Pathology, Central Finland Central Hospital, Keskussairaalantie 19, 40620 Jyv\u00e4skyl\u00e4, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niina","family":"Salokorpi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri","family":"Koivunen","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peeter","family":"Karihtala","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"},{"name":"Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Vuoristo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute of Diagnostics, Medical Research Center Oulu, Oulu University Hospital, Kajaanintie 50, 90220 Oulu, Finland,"},{"name":"Biocenter Oulu, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taina","family":"Turpeenniemi-Hujanen","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"},{"name":"Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Kuittinen","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"},{"name":"Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"key\n\t\t\t\t20180314051252_CIT0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpneuro0395","article-title":"Primary CNS lymphoma","volume":"3","author":"Hochberg","year":"(2007)","journal-title":"Nat. Clin. Pract. Neurol"},{"key":"key\n\t\t\t\t20180314051252_CIT0002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1008260120532","article-title":"For which patients with aggressive non-Hodgkin\u2019s lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group","volume":"9","author":"Bos","year":"(1998)","journal-title":"Ann. Oncol"},{"key":"key\n\t\t\t\t20180314051252_CIT0003","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","article-title":"Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma","volume":"91","author":"van Besien","year":"(1998)","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180314051252_CIT0004","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00277-010-1150-7","article-title":"Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab","volume":"90","author":"Tai","year":"(2011)","journal-title":"Ann. Hematol"},{"key":"key\n\t\t\t\t20180314051252_CIT0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0609.2010.01438.x","article-title":"Central nervous system involvement in diffuse large B-cell lymphoma","volume":"85","author":"Yamamoto","year":"(2010)","journal-title":"Eur. J. Haematol"},{"key":"key\n\t\t\t\t20180314051252_CIT0006","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/annonc\/mds621","article-title":"Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell\/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study","volume":"24","author":"Holte","year":"(2013)","journal-title":"Ann. Oncol"},{"key":"key\n\t\t\t\t20180314051252_CIT0007","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2003-02-0542","article-title":"Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma","volume":"102","author":"Tilly","year":"(2003)","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180314051252_CIT0008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.blre.2011.12.001","article-title":"CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom?","volume":"26","author":"Siegal","year":"(2012)","journal-title":"Blood Rev"},{"key":"key\n\t\t\t\t20180314051252_CIT0009","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/ejh.12626","article-title":"Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study","volume":"96","author":"Lemma","year":"(2016)","journal-title":"Eur. J. Haematol"},{"key":"key\n\t\t\t\t20180314051252_CIT0010","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood-2003-10-3611","article-title":"CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem\/progenitor cells to bone marrow","volume":"103","author":"Avigdor","year":"(2004)","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180314051252_CIT0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1476-4598-12-85","article-title":"PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12\/CXCR4 signaling","volume":"12","author":"Conley-LaComb","year":"(2013)","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t20180314051252_CIT0012","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V95.11.3289","article-title":"The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial\/stromal migration and engraftment of NOD\/SCID mice","volume":"95","author":"Peled","year":"(2000)","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180314051252_CIT0013","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1091\/mbc.E13-07-0360","article-title":"CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways","volume":"25","author":"Sobolik","year":"(2014)","journal-title":"Mol. Biol. Cell"},{"key":"key\n\t\t\t\t20180314051252_CIT0014","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/ar.22821","article-title":"The effect of CXCR4 silencing on epithelial-mesenchymal transition related genes in glioma U87 cells","volume":"296","author":"Zhu","year":"(2013)","journal-title":"Anat. Rec. (Hoboken)"},{"key":"key\n\t\t\t\t20180314051252_CIT0015","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1007\/s13277-015-4555-z","article-title":"Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT","volume":"37","author":"Ma","year":"(2016)","journal-title":"Tumour Biol"},{"key":"key\n\t\t\t\t20180314051252_CIT0016","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-cellbio-092910-154036","article-title":"The ins and outs of the epithelial to mesenchymal transition in health and disease","volume":"27","author":"Nieto","year":"(2011)","journal-title":"Annu. Rev. Cell Dev. Biol"},{"key":"key\n\t\t\t\t20180314051252_CIT0017","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/carcin\/bgt340","article-title":"ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin \u03b15 expression","volume":"35","author":"Nam","year":"(2014)","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20180314051252_CIT0018","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"(2012)","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"key\n\t\t\t\t20180314051252_CIT0019","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-015-0448-4","article-title":"P-cadherin and the journey to cancer metastasis","volume":"14","author":"Vieira","year":"(2015)","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t20180314051252_CIT0020","first-page":"3783","article-title":"The role of CD44 in epithelial-mesenchymal transition and cancer development","volume":"8","author":"Xu","year":"(2015)","journal-title":"Onco. Targets. Ther"},{"key":"key\n\t\t\t\t20180314051252_CIT0021","doi-asserted-by":"crossref","first-page":"351","DOI":"10.18632\/oncotarget.1449","article-title":"ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells","volume":"5","author":"Mochmann","year":"(2014)","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180314051252_CIT0022","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2141.1987.tb06916.x","article-title":"Beta 2-microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukaemia: relationship to CNS involvement and the effect of prophylactic intrathecal treatment with methotrexate","volume":"66","author":"Oberg","year":"(1987)","journal-title":"Br. J. Haematol"},{"key":"key\n\t\t\t\t20180314051252_CIT0023","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.febslet.2011.12.011","article-title":"Human lactoferrin suppresses TNF-\u03b1-induced intercellular adhesion molecule-1 expression via competition with NF-\u03baB in endothelial cells","volume":"586","author":"Kim","year":"(2012)","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20180314051252_CIT0024","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/10428194.2011.624226","article-title":"Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas","volume":"53","author":"Pasanen","year":"(2012)","journal-title":"Leuk. Lymphoma"},{"key":"key\n\t\t\t\t20180314051252_CIT0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"(2004)","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180314051252_CIT0026","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1073\/pnas.98.1.31","article-title":"Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection","volume":"98","author":"Li","year":"(2001)","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180314051252_CIT0027","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1002\/cncr.25278","article-title":"Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma","volume":"116","author":"Abramson","year":"(2010)","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180314051252_CIT0028","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/bjh.13194","article-title":"Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"168","author":"Ferreri","year":"(2015)","journal-title":"Br. J. Haematol"},{"key":"key\n\t\t\t\t20180314051252_CIT0029","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ajh.23467","article-title":"Recent advances in de novo CD5+ diffuse large B cell lymphoma","volume":"88","author":"Jain","year":"(2013)","journal-title":"Am. J. Hematol"},{"key":"key\n\t\t\t\t20180314051252_CIT0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/bjh.12982","article-title":"Double hit lymphoma: the MD Anderson Cancer Center clinical experience","volume":"166","author":"Oki","year":"(2014)","journal-title":"Br. J. Haematol"},{"key":"key\n\t\t\t\t20180314051252_CIT0031","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1182\/blood-2015-10-676700","article-title":"Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL","volume":"127","author":"Savage","year":"(2016)","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180314051252_CIT0032","first-page":"763","article-title":"Selective central nervous system tropism of primary central nervous system lymphoma","volume":"3","author":"Jiang","year":"(2010)","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"key\n\t\t\t\t20180314051252_CIT0033","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2010-07-297861","article-title":"Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma","volume":"117","author":"Sung","year":"(2011)","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180314051252_CIT0034","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1182\/blood-2007-10-119099","article-title":"Pathway analysis of primary central nervous system lymphoma","volume":"111","author":"Tun","year":"(2008)","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180314051252_CIT0035","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1182\/blood-2013-01-476333","article-title":"CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma","volume":"121","author":"Rubenstein","year":"(2013)","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180314051252_CIT0036","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2012.02.035","article-title":"SDF-1\/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway","volume":"322","author":"Li","year":"(2012)","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t20180314051252_CIT0037","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.celrep.2015.06.059","article-title":"CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation","volume":"12","author":"Roccaro","year":"(2015)","journal-title":"Cell Rep"},{"key":"key\n\t\t\t\t20180314051252_CIT0038","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.canlet.2014.08.012","article-title":"SDF-1\/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt\/\u03b2-catenin signaling pathway","volume":"354","author":"Hu","year":"(2014)","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t20180314051252_CIT0039","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12032-014-0377-x","article-title":"SDF-1\/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K\/AKT pathway","volume":"32","author":"Yang","year":"(2015)","journal-title":"Med. Oncol"},{"key":"key\n\t\t\t\t20180314051252_CIT0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00190136","article-title":"Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix","volume":"188","author":"Bignami","year":"(1993)","journal-title":"Anat. Embryol. (Berl)"},{"key":"key\n\t\t\t\t20180314051252_CIT0041","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/neuonc\/not012","article-title":"Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma","volume":"15","author":"He","year":"(2013)","journal-title":"Neuro. Oncol"},{"key":"key\n\t\t\t\t20180314051252_CIT0042","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"(2000)","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180314051252_CIT0043","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","article-title":"Integrin signalling during tumour progression","volume":"5","author":"Guo","year":"(2004)","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"key\n\t\t\t\t20180314051252_CIT0044","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"(2012)","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"key\n\t\t\t\t20180314051252_CIT0045","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/jid.2015.27","article-title":"The high expression of the microRNA 17-92 cluster and its paralogs, and the downregulation of the target gene PTEN, is associated with primary cutaneous B-cell lymphoma progression","volume":"135","author":"Battistella","year":"(2015)","journal-title":"J. Invest. Dermatol"},{"key":"key\n\t\t\t\t20180314051252_CIT0046","first-page":"14875","article-title":"Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL","volume":"8","author":"Ma","year":"(2015)","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"key\n\t\t\t\t20180314051252_CIT0047","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.expneurol.2013.11.017","article-title":"Nuclear trafficking of Pten after brain injury leads to neuron survival not death","volume":"252","author":"Goh","year":"(2014)","journal-title":"Exp. Neurol"},{"key":"key\n\t\t\t\t20180314051252_CIT0048","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-328X(01)00216-9","article-title":"Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment","volume":"96","author":"Fillebeen","year":"(2001)","journal-title":"Brain Res. Mol. Brain Res"},{"key":"key\n\t\t\t\t20180314051252_CIT0049","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/bjc.2015.29","article-title":"Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells","volume":"112","author":"Ricciardi","year":"(2015)","journal-title":"Br. J. Cancer"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/38\/8\/812\/24346786\/bgx061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T22:42:05Z","timestamp":1719268925000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/38\/8\/812\/3976624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,7,17]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgx061","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,7,17]]}}}